Diabetes Research and Clinical Practice 1991: Vol 13 Index

9 Pages·1991·1.9 MB·English

Diabetes Research and Clinical Practice, 13 (1991) 223-226
© 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50
Author Index to Volume 13 (1991)
Ahrén, B., Pettersson, M., Uvnas-Moberg, K., Gutniak, M. Duner, E., see Bruttomesso, D., 15
and Efendic, S., Effects of cholecystokinin (CCK)-8, Durlach, V., see Grulet, H., 189
CCK-33, and gastric inhibitory polypeptide (GIP) on
basal and meal-stimulated pancreatic hormone secretion Efendic, S., see Ahrén, B., 153
in man, 153 Eggstein, M., see Lingenfelser, Th., 29
Alberti, K.G.M.M., see Davis, S.N., 107 Fernando, D.J.S., see Kumar, S., 63
Andersson, P.-O., see Wikby, A., 53 Fongher, C., see Bruttomesso, D., 15
Aoki, Y., Yanagisawa, Y., Ohfusa, H., Kawa, S., Oguchi, H. Forrest, R.D., see Yudkin, J.S., 1
and Furuta, S., Elevation of serum CA 19-9 in parallel Fujimoto, W.Y., Leonetti, D.L., Bergstrom, R.W., Kinyoun,
with HbA,, in a diabetic female with the Lewis(a + b — ) J.L., Stolov, W.C. and Wahl, P.W., Glucose intolerance
blood group, 77 and diabetic complications among Japanese- American
Asha Bai, P.V., Krishnaswami, C.V., Chellamariappan, M.., women, 119
Vijaya Kumar, G. and Subramaniam, J.R., Glycosuria Fukuda, M., see Cha, T., 181
and diabetes mellitus in children and adolescents in south Furuta, S., see Aoki, Y., 77
India, 131
Gliick, H., see Lingenfelser, Th., 29
Baba, S., see Yoshida, M., 147 Griffing, G., see Kimmerle, R., 69
Bergstrom, R.W., see Fujimoto, W.Y., 119 Gross, A., see Grulet, H., 189
Biolo, G., see Bruttomesso, D., 15 Grulet, H., Gross, A., Pasqual, C., Durlach, V. and
Boulton, A.J.M., see Kumar, S., 63 Leutenegger, M., Remission of insulin requirement in late
Briani, G., see Bruttomesso, D., 15 secondary failure to oral hypoglycemic agents (IRD):
Brown, M.D., see Davis, S.N., 107 results at 24 months and analysis of predictive factors,
Bruttomesso, D., Biolo, G., Inchiostro, S., Fongher, C., 189
Briani, G., Duner, E., Marescotti, M.C., Iori, E., Tiengo, Gutniak, M., see Ahrén, B., 153
A. and Tessari, P., No effects of high-fiber diets on
metabolic control and insulin-sensitivity in type 1 Harano, Y., see Suzuki, M., 163
diabetic subjects, 15 Hidaka, H., see Suzuki, M., 163
Home, P.D., see Davis, S.N., 107
Cha, T., Tahara, Y., Ikegami, H., Fukuda, M., Yoneda, H., Hong, S.Y., see Cho, Y.W., 139
Yamato, E., Yamamoto, Y., Noma, Y., Shima, K. and Hozumi, T., see Yoshida, M., 147
Ogihara, T., Urinary C-peptide as an index of unstable Huh, K.B., see Cho, Y.W., 139
glycemic control in insulin- dependent diabetes mellitus Hoérnquist, J.O., see Wikby, A., 53
(IDDM), 181
Chellamariappan, M., see Asha Bai, P.V., 131 Ikegami, H., see Cha, T., 181
Cho, Y.W., Oh, D.Y., Kim, S.J., Hong, S.Y., Lee, H.C. and Inchiostro, S., see Bruttomesso, D., 15
Huh, K.B., Euglobulin fibrinolytic activity in NIDDM Iori, E., see Bruttomesso, D., 15
patients, 139 Ishida, Y., see Yoshida, M., 147
Cullen, D.R., see Tesfaye, S., 83 Isotani, H., see Majima, T., 207
Itakura, M., see Kunika, K., 37
Davis, S.N., Thompson, C.J., Brown, M.D., Home, P.D. and Iwama, N., see Lee, J.Y., 173
Alberti, K.G.M.M., A comparison of the pharmaco-
kinetics and metabolic effects of human regular and NPH Jackson, C.A., see Yudkin, J.S., 1
insulin mixtures, 107 Jakober, B., see Lingenfelser, Th., 29
Doi, K., see Yoshida, M., 147
224
Kamada, T., see Lee, J.Y., 173 postpartum thyrotoxicosis: a case report, 207
Kamado, K., see Sasaki, A., 213 Marescotti, M.C., see Bruttomesso, D., 15
Kashigawi, A., see Suzuki, M., 163 McCall, A., see Kimmerle, R., 69
Katsumata, K., Okada, T., Miyao, M. and Katsumata, Y., Melby, J.C., see Kimmerle, R., 69
High incidence of sleep apnea syndrome in a male diabetic Mimoto, H., see Yoshida, M., 147
population, 45 Miyao, M., see Katsumata, K., 45
Katsumata, Y., see Katsumata, K., 45
Kawa, S., see Aoki, Y., 77 Nakano, T., see Suzuki, M., 163
Kawamori, R., see Lee, J.Y., 173 Nieuwenhuijzen Kruseman, A.C., see Wolffenbuttel, B.H.R.,
Kazumi, T., see Yoshida, M., 147 199
Kerp, L., see Petersen, K.-G., 23 Noma, Y., see Cha, T., 181
Khalaf, A., see Petersen, K.-G., 23
Khoja, S.M. and Salem, A.M., Regulation of 6-phospho- Ogihara, T., see Cha, T., 181
fructo-1-kinase in the placenta and small intestine of Oguchi, H., see Aoki, Y., 77
pregnant streptozotocin-induced diabetic rats, 85 Oh, D.Y., see Cho, Y.W., 139
Kim, S.J., see Cho, Y.W., 139 Ohfusa, H., see Aoki, Y., 77
Kimmerle, R., Griffing, G., McCall, A., Ruderman, N.B., Ohsawa, N., see Majima, T., 207
Stolz, E. and Melby, J.C., Could intranasal insulin be Okada, T., see Katsumata, K., 45
useful in the treatment of non-insulin-dependent diabetes Overkamp, D., see Lingenfelser, Th., 29
mellitus?, 69
Kinyoun, J.L., see Fujimoto, W.Y., 119 Papaccio, G., Prevention of low dose streptozotocin-induced
Kitazawa, A., see Majima, T., 207 diabetes by acetyl- homocysteine-thiolactone, 95
Knols, A.J.F., see Wolffenbuttel, B.H.R., 199 Pasqual, C., see Grulet, H., 189
Knowles, E.A., see Kumar, S., 63 Petersen, K.-G., Khalaf, A. and Kerp, L., Lack of B,-adreno-
Kojima, H., see Suzuki, M., 163 ceptor induced long-acting effect on glucose tolerance in
Kosugi, K., see Suzuki, M., 163 type 2 diabetic patients, 23
Krishnaswami, C.V., see Asha Bai, P.V., 131 Pettersson, M., see Ahrén, B., 153
Kumar, S., Fernando, D.J.S., Veves, A., Knowles, E.A.,
Young, M.J. and Boulton, A.J.M., Semmes-Weinstein Raskin, P., see Sullivan, K., 103
monofilaments: a simple, effective and inexpensive Renn, W., see Lingenfelser, Th., 29
screening device for identifying diabetic patients at risk of Ruderman, N.B., see Kimmerle, R., 69
foot ulceration, 63
Kunika, K., Itakura, M. and Yamashita, K., Correction of Sakane, S., see Majima, T., 207
fructosamine value for serum albumin and globulin con- Salem, A.M., see Khoja, S.M., 85
centrations, 37 Sasaki, A., Kamado, K. and Uehara, M., A changing pattern
of causes of death among diabetic patients during a
Lee, H.C., see Cho, Y.W., 139 25-year period in the Osaka District, Japan, 213
Lee, J.Y., Iwama, N., Watarai, T., Yamamsaki, Y., Sasaki, E., see Majima, T., 207
Kawamori, R. and Kamada, T., Inhibitory effect of Sawa, J., see Yoshida, M., 147
methylguanidine on insulin binding to its receptor. Sels, J.-P.J.E., see Wolffenbuttel, B.H.R., 199
Mechanism underlying insulin resistance in uremia, 173 Shigeta, Y., see Suzuki, M., 163
Leonetti, D.L., see Fujimoto, W.Y., 119 Shima, K., see Cha, T., 181
Leutenegger, M., see Grulet, H., 189 Slits, W.L.H., see Wolffenbuttel, B.H.R., 199
Lingenfelser, Th., Overkamp, D., Renn, W., Gliick, H., Stolov, W.C., see Fujimoto, W.Y., 119
Maassen, M., Eggstein, M. and Jakober, B., Different Stoltz, E., see Kimmerle, R., 69
awareness of hypoglycaemia induced by human or puri- Subramanian, J.R., see Asha Bai, P.V., 131
fied pork insulin in type I diabetic patients, 29 Sullivan, K. and Raskin, P., Evaluation of a new automated
affinity-chromatographic method for the measurement of
Maassen, M., see Lingenfelser, Th., 29 glycated hemoglobin, 103
Majima, M., see Majima, T., 207 Suzuki, M., Kojima, H. Nakano, T., Kashiwagi, A., Hidaka,
Majima, T., Takamatsu, J., Isotani, H., Majima, M., Sakane, H., Kosugi, K., Shigeta, Y. and Harano, Y., In vitro
S., Yoshida, S., Sasaki, E., Taka, T., Kitazawa, A. and stimulation of glucose utilization by insulin in primary
Ohsawa, N., Insulin-dependent diabetes mellitus in cultures of rat hepatocytes, 163
which glycemic control was improved during pregnancy
but deteriorated after delivery with the occurrence of Tahara, Y., see Cha, T., 181
225
Taka, T., see Majima, T., 207 Wolffenbuttel, B.H.R., van Vliet, S., Knols, A.J.F., Slits,
Takamatsu, J., see Majima, T., 207 W.L.H., Sels, J.-P.J.E. and Nieuwenhuijzen Kruseman,
Tesfaye, S., Cullen, D.R., Wilson, R.M. and Woolley, P.D., A.C., Clinical characteristics and management of diabetic
Diabetic ketoacidosis precipitated by genital herpes patients residing in a nursing home, 199
infection, 83 Woolley, P.D., see Tesfaye, S., 83
Tessari, P., see Bruttomesso, D., 15
Thompson, C.J., see Davis, S.N., 107 Yamamoto, Y., see Cha, T., 181
Tiengo, A., see Bruttomesso, D., 15 Yamasaki, Y., see Lee, J.Y., 173
Yamashita, K., see Kunika, K., 37
Uehara, M., see Sasaki, A., 213 Yamato, E., see Cha, T., 181
Uvnis-Moberg, see Ahrén, B., 153 Yanagisawa, Y., see Aoki, Y., 77
Yoneda, H., see Cha, T., 181
van Vliet, S., see Wolffenbuttel, B.H.R., 199 Yoshida, M., Sawa, J., Hozumi, T., Mimoto, H., Ishida, Y.,
Veves, A., see Kumar, S., 63 Kazumi, T., Doi, K. and Baba, S., Effects of long-term
Vijaya Kumar, G., see Asha Bai, P.V., 131 high-fiber diet on macrovascular changes and lipid and
glucose levels in STZ-induced diabetic SD rats, 147
Wahl, P.W., see Fujimoto, W.Y., 119 Yoshida, S., see Majima, T., 207
Watarai, T., see Lee, J.Y., 173 Young, M.J., see Kumar, S., 63
Wikby, A., Hdérnquist, J.O. and Andersson, P.-O., Yudkin, J.S., Forrest, R.D. and Jackson, C.A., Misclassifi-
Background, quality of life and metabolic control in cation of diabetic subjects may account for the increased
patients with insulin-dependent diabetes mellitus, 53 vascular risk of impaired glucose tolerance: the Islington
Wilson, R.M., see Tesfaye, S., 83 Diabetes Survey, 1
sachs
Diabetes Research and Clinical Practice, 13 (1991) 227-230
© 1991 Elsevier Science Publishers B.V. 0168-8227/91/$03.50
Key Word Index to Volume 13 (1991)
B-Adrenergic effect Peripheral vascular disease; Hypertension; Glucose tol-
— Type 2 diabetes mellitus; Glucose tolerance; Hyper- erance test, 1
glycemia; Hyperinsulinemia, 23 Coronary heart disease
Albumin — Complication; Diabetes; Epidemiology; Hypertension;
— Fructosamine; Globulin; Glycation; Diabetes mellitus, Impaired glucose tolerance; Japanese-American; Periph-
37 eral vascular disease; Women, 119
Atheroma formation
— High-fiber diet; Macrovascular change, 147 Death certificate
Autonomic and neuroglycopenic symptoms — Diabetes mellitus; Causes of death; Multiple coding
— Diabetes mellitus; IDDM; Hypoglycaemia; Unaware- system; Long-term observation, 213
ness; Hormonal counterregulation, 29 Diabetes
- Phosphofructokinase; Insulin; Pregnant; Placenta;
Biothesiometer Small intestine, 85
— Foot ulcers; Neuropathy; Monofilaments, 63 Diabetes
Blood glucose control — Coronary heart disease; Complication; Epidemiology;
— Diabetes mellitus; Nursing home; Stroke; Hyper- Hypertension; Impaired glucose tolerance; Japanese-
tension; Cardiovascular disease; Lipids, 199 American; Peripheral vascular disease; Women, 119
Body type Diabetes mellitus
-— Sleep apnea syndrome; Diabetes mellitus; Hyper- — High-fiber diet; Metabolic control; Insulin-sensitivity,
tension, 45 15
Brittle diabetes Diabetes mellitus
— Urinary C-peptide excretion; Residual f-cell function; -IDDM; Hypoglycaemia; Unawareness; Autonomic
Glycemic stability, 181 and neuroglycopenic symptoms; Hormonal counterregu-
lation, 29
CA 19-9 Diabetes mellitus
— Sex; Lewis blood group; Hyperglycemia, 77 - Fructosamine; Albumin; Globulin; Glycation, 37
Cardiovascular disease Diabetes mellitus
— Diabetes mellitus; Nursing home; Stroke; Hyper- — Sleep apnea syndrome; Hypertension; Body type, 45
tension; Blood glucose control; Lipids, 199 Diabetes mellitus
Causes of death — Glycosylated hemoglobin, 103
— Diabetes mellitus; Death certificate; Multiple coding Diabetes mellitus
system; Long-term observation, 213 — Nursing home; Stroke; Hypertension; Cardiovascular
Cholecystokinin disease; Blood glucose control; Lipids, 199
— GIP; Insulin secretion; Glucagon secretion; Somato- Diabetes mellitus
statin secretion; Pancreatic polypeptide secretion; In — Death certificate; Causes of death; Multiple coding sys-
vivo; Man, 153 tem; Long-term observation, 213
Citiolone Diabetic retinopathy
— Type 1 diabetes; Stretozotocin; Syperoxide dismutase, — Euglobulin fibrinolytic activity, 139
95
Complication Enzyme activation
—Coronary heart disease; Diabetes; Epidemiology; — Hepatocyte; Glucose utilization; Insulin action;
Hypertension; Impaired glucose tolerance; Japanese- Enzyme induction, 163
American; Peripheral vascular disease; Women, 119 Enzyme induction
Coronary heart disease — Hepatocyte; Glucose utilization; Insulin action;
—Impaired glucose tolerance; Macrovascular disease; Enzyme activation, 163
228
Epidemiology — Diabetes mellitus; IDDM; Hypoglycaemia; Unaware-
-Coronary heart disease; Complication; Diabetes; ness; Autonomic and neuroglycopenic symptoms, 29
Hypertension; Impaired glucose tolerance; Japanese- Hyperglycemia
American; Peripheral vascular disease; Women, 119 — Type 2 diabetes mellitus; B,-adrenergic effect; Glucose
Euglobulin fibrinolytic activity tolerance; Hyperinsulinemia, 23
— Diabetic retinopathy, 139 Hyperglycemia
-—CA 19-9; Sex; Lewis blood group, 77
Foot ulcers Hyperinsulinemia
— Neuropathy; Monofilaments; Biothesiometer, 63 — Type 2 diabetes mellitus; B,-adrenergic effect; Glucose
Fructosamine tolerance; Hyperglycemia, 23
-— Albumin; Globulin; Glycation; Diabetes mellitus, 37 Hypertension
—Impaired glucose tolerance; Macrovascular disease;
GIP Peripheral vascular disease; Coronary heart disease;
— Cholecystokinin; Insulin secretion; Glucagon secre- Glucose tolerance test, 1
tion; Somatostatin secretion; Pancreatic polypeptide Hypertension
secretion; In vivo; Man, 153 — Sleep apnea syndrome; Diabetes mellitus; Body type,
Genital herpes 45
- Ketoacidosis, 83 Hypertension
Globulin -— Coronary heart disease; Complication; Diabetes; Epi-
— Fructosamine; Albumin; Glycation; Diabetes mellitus, demiology; Impaired glucose tolerance; Japanese-
37 American; Peripheral vascular disease; Women, 119
Glucagon secretion Hypertension
— Cholecystokinin; GIP; Insulin secretion; Somatostatin — Diabetes mellitus; Nursing home; Stroke; Cardio-
secretion; Pancreatic polypeptide secretion; In vivo; vascular disease; Blood glucose control; Lipids, 199
Man, 153 Hypoglycaemia
Glucose tolerance test — Diabetes mellitus; IDDM; Unawareness; Autonomic
—Impaired glucose tolerance; Macrovascular disease; and neuroglycopenic symptoms; Hormonal counterregu-
Peripheral vascular disease; Hypertension; Coronary lation, 29
heart disease, 1
Glucose tolerance IDDM
— Type 2 diabetes mellitus; B,-adrenergic effect; Hyper- -— Diabetes mellitus; Hypoglycaemia; Unawareness;
glycemia; Hyperinsulinemia, 23 Autonomic and neuroglycopenic symptoms; Hormonal
Glucose utilization counterregulation, 29
-— Hepatocyte; Insulin action; Enzyme activation; En- IDDM
zyme induction, 163 — Glycosuria; NIDDY (MODY); Incidence, 131
Glycation IDDM
- Fructosamine; Albumin; Globulin; Diabetes mellitus, — Slowly progressive IDDM; Pregnancy; Postpartum
37 thyroiditis, 207
Glycemic stability Impaired glucose tolerance
— Urinary C-peptide excretion; Brittle diabetes; Residual — Macrovascular disease; Peripheral vascular disease;
B-cell function, 181 Hypertension; Coronary heart disease; Glucose toler-
Glycosuria ance test, 1
- IDDM; NIDDY (MODY); Incidence, 131 Impaired glucose tolerance
Glycosylated hemoglobin — Coronary heart disease; Complication; Diabetes; Epi-
— Diabetes mellitus, 103 demiology; Hypertension; Japanese-American; Periph-
eral vascular disease; Women, 119
Hepatocyte In vivo
— Glucose utilization; Insulin action; Enzyme activation; — Cholecystokinin; GIP; Insulin secretion; Glucagon
Enzyme induction, 163 secretion; Somatostatin secretion; Pancreatic polypep-
High-fiber diet
tide secretion; Man, 153
— Metabolic control; Insulin-sensitivity; Diabetes mel- Incidence
litus, 15 — Glycosuria; IDDM; NIDDY (MODY), 131
High-fiber diet Insulin
— Macrovascular change; Atheroma formation, 147 — Nasal drug therapy; NIDDM, 69
Hormonal counterregulation Insulin
229
- Phosphofructokinase; Diabetes; Pregnant; Placenta; secretion; Somatostatin secretion; Pancreatic polypep-
Small intestine, 85 tide secretion; In vivo, 153
Insulin action Metabolic control
— Hepatocyte; Glucose utilization; Enzyme activation; — High-fiber diet; Insulin-sensitivity; Diabetes mellitus,
Enzyme induction, 163 15
Insulin pump Methylguanidine
— Type 2 diabetes; Insulin-requiring diabetes; Remission; - Insulin receptor; Insulin resistance; Uremia, 173
Predictive factors, 189 Monofilaments
Insulin receptor — Foot ulcers; Neuropathy; Biothesiometer, 63
— Insulin resistance; Uremia; Methylguanidine, 173 Multiple coding system
Insulin resistance — Diabetes mellitus; Death certificate; Causes of death;
— Insulin receptor; Uremia; Methylguanidine, 173 Long-term observation, 213
Insulin secretion
— Cholecystokinin; GIP; Glucagon secretion; Somato- NIDDM
statin secretion; Pancreatic polypeptide secretion; In — Nasal drug therapy; Insulin, 69
vivo; Man, 153 NIDDY (MODY)
Insulin therapy — Glycosuria; IDDM; Incidence, 131
— Intermediary metabolism, 107 Nasal drug therapy
Insulin-dependent diabetes mellitus - Insulin; NIDDM, 69
— Social background; Quality of life and metabolic con- Neuropathy
trol, 53 - Foot ulcers; Monofilaments; Biothesiometer, 63
Insulin-requiring diabetes Nursing home
— Type 2 diabetes; Remission; Insulin pump; Predictive — Diabetes mellitus; Stroke; Hypertension; Cardiovascu-
factors, 189 lar disease; Blood glucose control; Lipids, 199
Insulin-sensitivity
— High-fiber diet; Metabolic control; Diabetes mellitus, Pancreatic polypeptide secretion
15 — Cholecystokinin; GIP; Insulin secretion; Glucagon
Intermediary metabolism secretion; Somatostatin secretion; In vivo; Man, 153
— Insulin therapy, 107 Peripheral vascular disease
-—Impaired glucose tolerance; Macrovascular disease;
Japanese-American Hypertension; Coronary heart disease; Glucose toler-
— Coronary heart disease; Complication; Diabetes; Epi- ance test, 1
demiology; Hypertension; Impaired glucose tolerance; Peripheral vascular disease
Peripheral vascular disease; Women, 119 — Coronary heart disease; Complication; Diabetes; Epi-
Ketoacidosis demiology; Hypertension; Impaired glucose tolerance;
— Genital herpes, 83 Japanese-American; Women, 119
Phosphofructokinase
Lewis blood group — Diabetes; Insulin; Pregnant; Placenta; Small intestine,
-CA 19-9; Sex; Hyperglycemia, 77 85
Lipids Placenta
- Diabetes mellitus; Nursing home; Stroke; Hyper- — Phosphofructokinase; Diabetes; Insulin; Pregnant;
tension; Cardiovascular disease; Blood glucose control, Small intestine, 85
199 Postpartum thyroiditis
Long-term observation - IDDM; Slowly progressive IDDM; Pregnancy, 207
— Diabetes mellitus; Death certificate; Causes of death; Predictive factors
Multiple coding system, 213 — Type 2 diabetes; Insulin-requiring diabetes; Remission;
Insulin pump, 189
Macrovascular disease Pregnancy
— Impaired glucose tolerance; Peripheral vascular dis- - IDDM; Slowly progressive IDDM; Postpartum thy-
ease; Hypertension; Coronary heart disease; Glucose roiditis, 207
tolerance test, 1 Pregnant
Macrovascular change - Phosphofructokinase; Diabetes; Insulin; Placenta;
— High-fiber diet; Atheroma formation, 147 Small intestine, 85
Man
— Cholecystokinin; GIP; Insulin secretion; Glucagon Quality of life and metabolic control
230
— Insulin-dependent diabetes mellitus; Social — Diabetes mellitus; Nursing home; Hypertension;
background, 53 Cardiovascular disease; Blood glucose control; Lipids,
199
Remission Superoxide dismutase
- Type 2 diabetes; Insulin-requiring diabetes; Insulin — Type | diabetes; Streptozotocin; Citiolone, 95
pump; Predictive factors, 189
Residual f-cell function Type 1 diabetes
— Urinary C-peptide excretion; Brittle diabetes; Glycemic — Streptozotocin; Citiolone; Superoxide dismutase, 95
stability, 181 Type 2 diabetes mellitus
— fB,-adrenergic effect; Glucose tolerance; Hyper-
Sex glycemia; Hyperinsulinemia, 23
-CA 19-9; Lewis blood group; Hyperglycemia, 77 Type 2 diabetes
Sleep apnea syndrome — Insulin-requiring diabetes; Remission; Insulin pump;
— Diabetes mellitus; Hypertension; Body type, 45 Predictive factors, 189
Slowly progressive IDDM
- IDDM; Pregnancy; Postpartum thyroiditis, 207 Unawareness
Small intestine — Diabetes mellitus; IDDM; Hypoglycaemia; Autonomic
— Phosphofructokinase; Diabetes; Insulin; Pregnant; and neuroglycopenic symptoms; Hormonal counterregu-
Placenta, 85 lation, 29
Social background Uremia
— Insulin-dependent diabetes mellitus; Quality of life and — Insulin receptor; Insulin resistance; Methylguanidine,
metabolic control, 53 173
Somatostatin secretion Urinary C-peptide excretion
— Cholecystokinin; GIP; Insulin secretion; Glucagon - Brittle diabetes; Residual f-cell function; Glycemic
secretion; Pancreatic polypeptide secretion; In vivo; stability, 181
Man, 53
Streptozotocin Women
-— Type | diabetes; Citiolone; Superoxide dismutase, 95 - Coronary heart disease; Complication; Diabetes; Epi-
Stroke demiology; Hypertension; Impaired glucose tolerance;
Japanese-American; Peripheral vascular disease, 119